<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02743273</url>
  </required_header>
  <id_info>
    <org_study_id>1507-028-686</org_study_id>
    <nct_id>NCT02743273</nct_id>
  </id_info>
  <brief_title>Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics</brief_title>
  <official_title>Identification of Prognostic Urinary Biomarker for Acute Kidney Injury in Preterm Infants by Proteomics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical definitions of acute kidney injury (AKI) have been based on an increase in serum&#xD;
      creatinine and a decrease in urine output. However, applying this definition to neonates&#xD;
      remains challenging because of the normal renal physiologic features that serum creatinine&#xD;
      levels are expected to increase in the first days after birth, and impaired sodium&#xD;
      reabsorption and concentrating ability.&#xD;
&#xD;
      Because of several limitations of early detection of AKI, investigators are focused on&#xD;
      identifying biomarkers that predict AKI before an increase serum creatinine level.&#xD;
&#xD;
      Investigators will collect urine from preterm infants before and after administrating&#xD;
      ibuprofen for closing patent ductus arteriosus. To identify novel biomarkers, investigators&#xD;
      will analyze urine by proteomics. To verify those biomarkers, investigators will use initial&#xD;
      urine on the first day of life from preterm infants who diagnosed AKI within 7 days after&#xD;
      birth without any risk factors for AKI and enrolled institutional bio-repository.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2015</start_date>
  <completion_date type="Actual">November 2017</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Months</target_duration>
  <primary_outcome>
    <measure>change the level of novel urinary biomarkers after ibuprofen administration</measure>
    <time_frame>change from 1 day before ibuprofen administration to 1 day after ibuprofen administration</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The level of novel urinary biomarkers in initial urine</measure>
    <time_frame>within 24 hours after birth</time_frame>
  </secondary_outcome>
  <enrollment type="Actual">37</enrollment>
  <condition>Acute Kidney Injury</condition>
  <eligibility>
    <study_pop>
      <textblock>
        1. Preterm infants with gestational age&lt;32 weeks or birth weight&lt;1,500 g who enrolled our&#xD;
             institutional prospective cohort study for biorepository.&#xD;
&#xD;
          2. Preterm infants with gestational age&lt;32 weeks or birth weight&lt; 1,500 g who need&#xD;
             ibuprofen treatment for closing patent ductus arteriosus.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Preterm infants less than 32 weeks gestational age or birth weight less than 1,500 g&#xD;
             admitted to the neonatal intensive care unit at Seoul National University Children's&#xD;
             hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Congenital heart disease&#xD;
&#xD;
          -  Known major congenital anomalies of the kidney and urinary tract&#xD;
&#xD;
          -  Other genetic syndromes or medical conditions that preclude enrollment per judgement&#xD;
             of the attending neonatologist&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Han-Suk Kim, MD, PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Children's Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>December 9, 2015</study_first_submitted>
  <study_first_submitted_qc>April 14, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 19, 2016</study_first_posted>
  <last_update_submitted>July 18, 2018</last_update_submitted>
  <last_update_submitted_qc>July 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Han-Suk Kim</investigator_full_name>
    <investigator_title>Professor, Director of Neonatal Intensive Care Unit</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Kidney Injury</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

